Comparative in vitro bactericidal activity between cefepime and ceftazidime, alone and associated with amikacin, against carbapenem-resistant Pseudomonas aeruginosa strains
- 2 May 2000
- journal article
- research article
- Published by Elsevier BV in Diagnostic Microbiology and Infectious Disease
- Vol. 37 (1), 41-44
- https://doi.org/10.1016/s0732-8893(99)00156-x
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Resistance to β-Lactam Antibiotics in Pseudomonas aeruginosa Due to Interplay between the MexAB-OprM Efflux Pump and β-LactamaseAntimicrobial Agents and Chemotherapy, 1999
- Pseudomonas aeruginosa : a Survey of Resistance in 136 Hospitals in SpainAntimicrobial Agents and Chemotherapy, 1999
- Carbapenem Activities against Pseudomonas aeruginosa : Respective Contributions of OprD and Efflux SystemsAntimicrobial Agents and Chemotherapy, 1999
- Factors Associated with Improved Outcome of Pseudomonas aeruginosa Bacteremia in a Finnish University HospitalEuropean Journal of Clinical Microbiology & Infectious Diseases, 1998
- Antimicrobial Activity and Spectrum Investigation of Eight Broad-Spectrum β-Lactam Drugs: A 1997 Surveillance Trial in 102 Medical Centers in the United StatesDiagnostic Microbiology and Infectious Disease, 1998
- Cefepime and amikacin synergy in vitro and in vivo against a ceftazidime-resistant strain of Enterobacter cloacae.Journal of Antimicrobial Chemotherapy, 1998
- Imipenem‐ResistantPseudomonas aeruginosa: Risk Factors and Antibiotic Susceptibility PatternsClinical Infectious Diseases, 1997
- CefepimeDrugs, 1994
- Development of resistance in Pseudomonas aeruginosa to broad-spectrum cephalosporins via step-wise mutationsJournal of Antimicrobial Chemotherapy, 1993
- Predominant pathogens in hospital infectionsJournal of Antimicrobial Chemotherapy, 1992